
How Trump's Medicare Move on Obesity Drugs Affects Your Spending and Healthcare Market
Trump's recent decision to drop a proposal for Medicare to cover expensive obesity drugs like Wegovy and Zepbound shakes up expectations for healthcar...
Stay updated with the latest market insights and press releases for LLY